Shield Therapeutics promotes Karis to chairman

By

Sharecast News | 22 Jan, 2019

14:05 05/11/24

  • 2.72
  • -2.68%-0.08
  • Max: 2.80
  • Min: 2.64
  • Volume: 1,517,616
  • MM 200 : n/a

Commercial stage pharmaceutical outfit Shield Therapeutics elevated James Karis to the role of non-executive chairman on Tuesday.

Last news

Sosandar signs licensing agreement with Next for homeware range
Saudi Aramco sees Q3 profits drop 15%
NatWest strikes £11bn deal to offload pension payments to Rothesay
Whitbread kicks off search for chair Crozier’s successor - report
RBC Capital adds 'speculative risk' qualifier to Close Brothers rating